0001824293-23-000163.txt : 20230926
0001824293-23-000163.hdr.sgml : 20230926
20230926160855
ACCESSION NUMBER: 0001824293-23-000163
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230922
FILED AS OF DATE: 20230926
DATE AS OF CHANGE: 20230926
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kelly Leanne
CENTRAL INDEX KEY: 0001398278
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40034
FILM NUMBER: 231280559
MAIL ADDRESS:
STREET 1: C/O VALLON PHARAMCEUTICALS, INC.
STREET 2: 100 N 18TH STREET, SUITE 300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
FORMER NAME:
FORMER CONFORMED NAME: Kelly Leanne M.
DATE OF NAME CHANGE: 20070502
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GRI BIO, Inc.
CENTRAL INDEX KEY: 0001824293
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 824369909
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2223 AVENIDA DE LA PLAYA
STREET 2: SUITE 208
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: (619) 400-1171
MAIL ADDRESS:
STREET 1: 2223 AVENIDA DE LA PLAYA
STREET 2: SUITE 208
CITY: LA JOLLA
STATE: CA
ZIP: 92037
FORMER COMPANY:
FORMER CONFORMED NAME: Vallon Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20200910
4
1
wk-form4_1695758927.xml
FORM 4
X0508
4
2023-09-22
0
0001824293
GRI BIO, Inc.
GRI
0001398278
Kelly Leanne
C/O GRI BIO, INC.
2223 AVENIDA DE LA PLAYA, SUITE 208
LA JOLLA
CA
92037
0
1
0
0
Chief Financial Officer
0
Stock Option (Right to Buy)
1.52
2023-09-22
4
A
0
83333
1.52
A
2033-09-22
Common Stock
83333
83333
D
Vests as to 25% of the underlying shares of common stock on the first annual anniversary of the date of grant, then in 36 equal monthly installments such that the stock option is fully vested on the fourth annual anniversary of the date of grant.
/s/ Leanne Kelly
2023-09-26